Immunisation with phage displaying peptides representing single epitopes of the glycoprotein G can give rise to partial protective immunity to HSV-2

被引:55
作者
Grabowska, AM [1 ]
Jennings, R
Laing, P
Darsley, M
Jameson, CL
Swift, L
Irving, WL
机构
[1] Univ Nottingham Hosp, Queens Med Ctr, Dept Microbiol, Nottingham NG7 2UH, England
[2] Univ Sheffield, Sch Med, Sheffield Inst Vaccine Studies, Div Med & Mol Genet, Sheffield, S Yorkshire, England
[3] Peptide Therapeut Ltd, Cambridge, England
关键词
D O I
10.1006/viro.2000.0185
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Filamentous phage displaying peptides representing single epitopes of the glycoprotein G of HSV-2 (gG2) were used as immunogens via the subcutaneous route in Balb/c mice without additional adjuvant. The phage were isolated from a random phage peptide display library and contain 15-mer peptide inserts that mimic epitopes of gG2. In each case, an antibody response to gG2 was generated that was dependent on the dose of phage administered and on the presence of the peptide insert. Phage displaying epitopes of gG2, which map to amino acids 551-570, were the most immunogenic; interestingly, this region of gG2 is frequently recognised by patients infected with HSV-2. The data also provide interesting information as regards choice of peptide mimics for use as immunogens because. surprisingly. the most antigenic of the individual clones was the least immunogenic. In two of the experiments, mice immunised with phage displaying a single epitope of gG2 were protected against challenge with a lethal dose of whole HSV-2. This suggests a possible role for phage-displayed peptides in inducing protective immunity against pathogens and provides a model system for investigating the underlying mechanisms. (C) 2000 Academic Press.
引用
收藏
页码:47 / 53
页数:7
相关论文
共 19 条
[1]   HERPES-SIMPLEX VIRUS-2 (HSV-2) TYPE-SPECIFIC ANTIBODY CORRELATES OF PROTECTION IN INFANTS EXPOSED TO HSV-2 AT BIRTH [J].
ASHLEY, RL ;
DALESSIO, J ;
BURCHETT, S ;
BROWN, Z ;
BERRY, S ;
MOHAN, K ;
COREY, L .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (02) :511-514
[2]   Immunization with a replication-deficient mutant of herpes simplex virus type 1 (HSV-1) induces a CD8(+) cytotoxic T-lymphocyte response and confers a level of protection comparable to that of wild-type HSV-1 [J].
Brehm, MA ;
Bonneau, RH ;
Knipe, DM ;
Tevethia, SS .
JOURNAL OF VIROLOGY, 1997, 71 (05) :3534-3544
[3]   BACULOVIRUS-EXPRESSED GLYCOPROTEIN-G OF HERPES-SIMPLEX VIRUS TYPE-1 PARTIALLY PROTECTS VACCINATED MICE AGAINST LETHAL HSV-1 CHALLENGE [J].
GHIASI, H ;
KAIWAR, R ;
NESBURN, AB ;
WECHSLER, SL .
VIROLOGY, 1992, 190 (01) :233-239
[4]   Identification of type-specific domains within glycoprotein G of herpes simplex virus type 2 (HSV-2) recognized by the majority of patients infected with HSV-2, but not by those infected with HSV-1 [J].
Grabowska, A ;
Jameson, C ;
Laing, P ;
Jeansson, S ;
Sjögren-Jansson, E ;
Taylor, J ;
Cunningham, A ;
Irving, WL .
JOURNAL OF GENERAL VIROLOGY, 1999, 80 :1789-1798
[5]   MULTIPLE DISPLAY OF FOREIGN PEPTIDES ON A FILAMENTOUS BACTERIOPHAGE - PEPTIDES FROM PLASMODIUM-FALCIPARUM CIRCUMSPOROZOITE PROTEIN AS ANTIGENS [J].
GREENWOOD, J ;
WILLIS, AE ;
PERHAM, RN .
JOURNAL OF MOLECULAR BIOLOGY, 1991, 220 (04) :821-827
[6]   Localization of type-specific epitopes of herpes simplex virus type 2 glycoprotein G recognized by human and mouse antibodies [J].
Liljeqvist, JÅ ;
Trybala, E ;
Svennerholm, B ;
Jeansson, S ;
Sjögren-Jansson, E ;
Bergström, T .
JOURNAL OF GENERAL VIROLOGY, 1998, 79 :1215-1224
[7]  
Marsden HS, 1998, J MED VIROL, V56, P79, DOI 10.1002/(SICI)1096-9071(199809)56:1&lt
[8]  
79::AID-JMV13&gt
[9]  
3.0.CO
[10]  
2-R